These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23834158)

  • 81. In vitro quality control of red blood cell concentrates outdated in clinical practice.
    Zimmermann R; Heidenreich D; Weisbach V; Zingsem J; Neidhardt B; Eckstein R
    Transfus Clin Biol; 2003 Sep; 10(4):275-83. PubMed ID: 14563416
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Quality control of buffy coat removed red cell concentrates--a Croatian experience.
    Vuk T; Očić T; Patko MS; Jukić I
    Transfus Med; 2014 Dec; 24(6):385-91. PubMed ID: 25469715
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Not all red cell concentrate units are equivalent: international survey of processing and in vitro quality data.
    Shih AW; Apelseth TO; Cardigan R; Marks DC; Bégué S; Greinacher A; de Korte D; Seltsam A; Shaz BH; Wikman A; Barty RL; Heddle NM; Acker JP;
    Vox Sang; 2019 Nov; 114(8):783-794. PubMed ID: 31637738
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Preparation of red blood cell concentrates and plasma units from whole blood held overnight using a hollow-fibre separation system.
    Johnson L; Kwok M; Marks DC
    Transfus Med; 2015 Feb; 25(1):13-9. PubMed ID: 25808374
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Quality control of leucocyte-depleted platelet concentrates obtained by buffy-coat method.
    Vuk T; Strauss Patko M; Gulan-Harcet J; Očić T; Šarlija D; Jukić I
    Transfus Med; 2013 Oct; 23(5):338-43. PubMed ID: 23772840
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Quality of red blood cells using autotransfusion devices: a comparative analysis.
    Serrick CJ; Scholz M; Melo A; Singh O; Noel D
    J Extra Corpor Technol; 2003 Mar; 35(1):28-34. PubMed ID: 12680493
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The effect of processing method on the in vitro characteristics of red blood cell products.
    Hansen AL; Kurach JD; Turner TR; Jenkins C; Busch MP; Norris PJ; Dugger J; Tomasulo PA; Devine DV; Acker JP
    Vox Sang; 2015 May; 108(4):350-8. PubMed ID: 25678039
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Quality assurance and quality control in component preparation.
    Pietersz RN
    Vox Sang; 1994; 67 Suppl 3():197-9. PubMed ID: 7975492
    [No Abstract]   [Full Text] [Related]  

  • 89. Delayed Leukoreduction of whole blood with a platelet-sparing filter to increase low-titer group O whole blood production in the United States.
    Wellington M; Feldman TP; Cleeton S; Sawyer S; Brown BL
    Transfusion; 2023 May; 63 Suppl 3():S177-S188. PubMed ID: 37071767
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Quality control of leucoreduced cellular blood components in France.
    Chabanel A; Andreu G; Carrat F; Hervé P
    Vox Sang; 2002 Feb; 82(2):67-71. PubMed ID: 11906669
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinical and quality evaluation of red blood cell units collected via apheresis versus those obtained manually.
    Hussein E; Enein A
    Lab Med; 2014; 45(3):238-43. PubMed ID: 25051076
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Research opportunities in optimizing storage of red blood cell products.
    Wagner SJ; Glynn SA; Welniak LA;
    Transfusion; 2014 Feb; 54(2):483-94. PubMed ID: 23676138
    [No Abstract]   [Full Text] [Related]  

  • 93. International views on universal leucodepletion: the perspective in Germany.
    Seitz MD
    Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155
    [No Abstract]   [Full Text] [Related]  

  • 94. Logistical problems of supplying leucodepleted blood components within the national blood service.
    Tandy N
    Transfus Sci; 1998 Dec; 19(4):373-4. PubMed ID: 10351160
    [No Abstract]   [Full Text] [Related]  

  • 95. Operational and research approaches to universal leucodepletion in Scotland.
    Prowse C
    Transfus Sci; 1998 Dec; 19(4):367-9. PubMed ID: 10351158
    [No Abstract]   [Full Text] [Related]  

  • 96. Blood components. Collection, processing, and storage.
    Schneider A
    Vet Clin North Am Small Anim Pract; 1995 Nov; 25(6):1245-61. PubMed ID: 8619264
    [TBL] [Abstract][Full Text] [Related]  

  • 97. International views on universal leucodepletion: the perspective in Portugal.
    de Sousa G
    Transfus Sci; 1998 Dec; 19(4):351-2. PubMed ID: 10351152
    [No Abstract]   [Full Text] [Related]  

  • 98. NBS approaches to the approval of suppliers of leucodepletion systems.
    Smith KJ
    Transfus Sci; 1998 Dec; 19(4):371-2. PubMed ID: 10351159
    [No Abstract]   [Full Text] [Related]  

  • 99. Implementation of a blood irradiation program at a community cancer center.
    Patton GA; Skowronski MG
    Transfusion; 2001 Dec; 41(12):1610-6. PubMed ID: 11778080
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Microarray kit analysis of cytokines in blood product units and segments.
    Weiskopf RB; Yau R; Sanchez R; Lowell C; Toy P
    Transfusion; 2009 Nov; 49(11):2269-75. PubMed ID: 19548981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.